EcoDrugPlus

Adrenoceptor Alpha 2c

Ensembl ID : ENSDLEG00000019419
Gene Symbol: ADRA2C
3 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSDLEG00000010832
Gene Symbol: ADRB1
3 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSDLEG00000003724
Gene Symbol: ADRB2
1 Cross references
265 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSDLEG00000006726
Gene Symbol: ADRB3
1 Cross references
218 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSDLEG00000018409
Gene Symbol: AGER
3 Cross references
170 Possible Orthologues:

Alcohol Dehydrogenase Class-3

Ensembl ID : ENSDLEG00000001104
Gene Symbol: LOC111179095
3 Cross references
402 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSDLEG00000007968
Gene Symbol: AKR1B1
3 Cross references
422 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSDLEG00000017311
Gene Symbol: AOC1
1 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSDLEG00000016813
Gene Symbol: AOC3
3 Cross references
326 Possible Orthologues:

Amylase Alpha 2a

Ensembl ID : ENSDLEG00000013294
Gene Symbol: AMY2A
3 Cross references
207 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSDLEG00000008511
Gene Symbol: APP
3 Cross references
279 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSDLEG00000014573
Gene Symbol: AR
3 Cross references
277 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).